导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 3.65% | 419/1050 |
| 近一周 | -2.27% | 517/1104 |
| 近一月 | -3.47% | 412/1102 |
| 近一季 | -7.97% | 579/1092 |
| 近半年 | -2.89% | 511/1070 |
| 近一年 | 1.67% | 547/1018 |
| 近两年 | 35.07% | 636/926 |
| 近三年 | 19.26% | 499/834 |
| 成立以来 | 68.84% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.97% 416/1070 |
15.61% 437/1101 |
- - |
- - |
| 2025 | 21.79% 633/1065 |
-1.17% 869/1014 |
-0.10% 695/1038 |
32.90% 324/1050 |
-7.18% 809/1065 |
| 2024 | -4.95% 706/1011 |
4.79% 109/960 |
-0.13% 317/983 |
-0.06% 958/991 |
-9.12% 878/1011 |
| 2023 | -20.61% 684/952 |
0.53% 606/880 |
-5.05% 523/895 |
-15.54% 785/915 |
-1.52% 198/952 |
| 2022 | -28.56% 588/867 |
-20.76% 558/773 |
19.06% 31/806 |
-12.02% 393/845 |
-13.94% 829/867 |
| 2021 | 21.46% 149/740 |
-12.02% 526/580 |
24.49% 97/659 |
6.20% 104/704 |
4.43% 248/740 |
| 2020 | 87.93% 66/554 |
3.29% 92/419 |
27.29% 157/466 |
11.08% 226/517 |
28.68% 43/554 |
| 2019 | - - |
- - |
- - |
- - |
5.90% 314/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 银华兴盛股票 VS. 东吴新产业精选股票A(580008) |